The Potential Impact of Contemporary Developments in the Management of Patients with Gastroesophageal Reflux Disease Undergoing an Initial Gastroscopy

Salem, Suhail B.; Kushner, Yaël B.; Marcus, Victoria; Mayrand, Serge; Fallone, Carlos A; Barkun, Alan N.

doi:10.1155/2009/859271

Cited by 8 publications

(7 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For example, the rate of esophageal adenocarcinogenesis discovered in this screening population was consistent with that reported for the general GERD population by other authors. 42-47 Also, previously established risk factors for esophageal adenocarcinogenesis, such as age, sex, ethnicity, and presence of hiatal hernia, were confirmed and reproduced in this study. Although this study is the first, to our knowledge, to examine the relationship among the severity of GERD symptoms, PPI use, and esophageal adenocarcinogenesis, others have demonstrated an increased risk of esophageal adenocarcinogenesis for patients taking PPIs.…”

Section: Commentsupporting

confidence: 82%

Gastroesophageal Reflux Disease Symptom Severity, Proton Pump Inhibitor Use, and Esophageal Carcinogenesis

Nason

Wichienkuer

Awais³

et al. 2011

Arch Surg

View full text Add to dashboard Cite

Section: Commentsupporting

confidence: 82%

Gastroesophageal Reflux Disease Symptom Severity, Proton Pump Inhibitor Use, and Esophageal Carcinogenesis

Nason

Wichienkuer

Awais³

et al. 2011

Arch Surg

View full text Add to dashboard Cite

“…A retrospective study of 353 patients with reflux symptoms reported that 7.7% of those biopsied at endoscopy had EoE. 22 A retrospective review of 161 patients having endoscopy for noncardiac chest pain reported that 6% had EoE. 23 An insidious onset of symptoms and self-taught coping strategies such as food avoidance (eg, difficult to swallow textures such as bread and meat) and drinking large volumes of water with meals, can delay patients recognition and reporting of symptoms.…”

Section: Clinical Presentationmentioning

confidence: 99%

Section: Clinical Presentationmentioning

confidence: 99%

British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults

Dhar

Haboubi

Attwood

et al. 2022

Gut

121

View full text Add to dashboard Cite

BackgroundEosinophilic oesophagitis (EoE) is an increasingly common cause of dysphagia in both children and adults, as well as one of the most prevalent oesophageal diseases with a significant impact on physical health and quality of life. We have provided a single comprehensive guideline for both paediatric and adult gastroenterologists on current best practice for the evaluation and management of EoE.MethodsThe Oesophageal Section of the British Society of Gastroenterology was commissioned by the Clinical Standards Service Committee to develop these guidelines. The Guideline Development Group included adult and paediatric gastroenterologists, surgeons, dietitians, allergists, pathologists and patient representatives. The Population, Intervention, Comparator and Outcomes process was used to generate questions for a systematic review of the evidence. Published evidence was reviewed and updated to June 2021. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system was used to assess the evidence and make recommendations. Two rounds of voting were held to assess the level of agreement and the strength of recommendations, with 80% consensus required for acceptance.ResultsFifty-seven statements on EoE presentation, diagnosis, investigation, management and complications were produced with further statements created on areas for future research.ConclusionsThese comprehensive adult and paediatric guidelines of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition are based on evidence and expert consensus from a multidisciplinary group of healthcare professionals, including patient advocates and patient support groups, to help clinicians with the management patients with EoE and its complications.

show abstract

“…Sofern eine Dysphagie oder eine Bolusobstruktion vorlagen liegt die Inzidenz sogar bei 23-50 %, beim Vorliegen therapierefraktärer GERD-Symptome oder bei nicht kardialen Thoraxschmerzen bei 0,9-8 % bzw. 6 % [24], [25], [26], [27]. Eine EoE kann in allen Altersklassen auftreten.…”

Section: Kommentarunclassified

Eosinophile Ösophagitis Update 2017: Neue Leitlinien der europäischen Studiengruppe EUREOS

Miehlke

Schlag

Storr³

et al. 2019

Laryngo-Rhino-Otol

View full text Add to dashboard Cite

ZusammenfassungDie eosinophile Ösophagitis gilt heute als eine der häufigsten Erkrankungen der Speiseröhre und eine der häufigsten Ursachen für Dysphagie und Bolusobstruktion bei Kindern und Erwachsenen. Die zunehmende Bedeutung dieser Erkrankung und neue klinisch-wissenschaftliche Erkenntnisse erforderten eine Aktualisierung der bis dato existierenden internationalen Leitlinien. Die europäische Studiengruppe Eosinophile Ösophagitis (EUREOS) hat daher, erstmals unter Verwendung der GRADE-Technik (Grading of Recommendations Assessment, Development, and Evaluation) mit Beteiligung aller relevanten Fachdisziplinen auf der Basis einer systematischen Literaturrecherche bis August 2015 neue Leitlinien zum Management der eosinophilen Ösophagitis bei Kindern und Erwachsenen erarbeitet. Das Ziel dieses Artikels ist es, die wichtigsten Neuerungen und klinische relevanten Empfehlungen der neuen Leitlinie zusammenzufassen und zu kommentieren.

show abstract

The Potential Impact of Contemporary Developments in the Management of Patients with Gastroesophageal Reflux Disease Undergoing an Initial Gastroscopy

Cited by 8 publications

References 22 publications

Gastroesophageal Reflux Disease Symptom Severity, Proton Pump Inhibitor Use, and Esophageal Carcinogenesis

Gastroesophageal Reflux Disease Symptom Severity, Proton Pump Inhibitor Use, and Esophageal Carcinogenesis

British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults

Eosinophile Ösophagitis Update 2017: Neue Leitlinien der europäischen Studiengruppe EUREOS

Contact Info

Product

Resources

About